Daily non-political popular news in brief.
A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer
10-13-2007 · EurekAlert!Type 2 diabetes mellitus is a risk factor for pancreatic cancer which is increasing worldwide. A research group from Turkey has found that the use of a tumor marker, Ca 19-9, in diabetics with a standard reference value can lead to misdiagnosis of pancreatic cancer.
Read more »
Keywords: tumor, marker, 19-9, diabetics, lead, misdiagnosis, pancreatic, cancer, diabetic, misdiagnosi
« Previous | Next »
Similar news on "A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer":
- Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
05-01-2007 · EurekAlert!
A pharmacologist at the Kimmel Cancer Center at Jefferson says that new findings suggesting a genetic marker can help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment have important implications for improved cancer diagnostics and tumor profiling. In an editorial he co-authored May 2 in JAMA, Scott Waldman, M.D., Ph.D., says that researchers at Ohio State University have identified "a new level of biological regulation."
Similar news · Read more »
- Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
10-11-2007 · EurekAlert!
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 -- which normally applies the brakes on a cancer-causing gene -- is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.
Similar news · Read more »
- Immunosuppressive drugs are a double-edged sword to type 1 diabetics
09-04-2007 · EurekAlert!
Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
Similar news · Read more »
- Cell receptor may lead to new 'biomarker' for pancreatic cancer
07-01-2007 · EurekAlert!
A research team led by University of Cincinnati scientists has identified a potential biological target for pancreatic cancer, a finding they say could help scientists better understand -- and eventually treat -- the disease that kills more than 33,000 people each year.
Similar news · Read more »
- Human C-reactive protein regulates myeloma tumor cell growth and survival
09-10-2007 · EurekAlert!
Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.
Similar news · Read more »
- Pumpkin: A fairytale end to insulin injections?
07-08-2007 · EurekAlert!
Compounds found in pumpkin could potentially replace or at least drastically reduce the daily insulin injections that so many diabetics currently have to endure. Recent research reveals that pumpkin extract promotes regeneration of damaged pancreatic cells in diabetic rats, boosting levels of insulin-producing beta cells and insulin in the blood. Chinese scientists found that diabetic rats fed the extract had only 5 percent less plasma insulin and 8 percent fewer insulin-positive cells compared to normal healthy rats.
Similar news · Read more »
- New study reveals for first time how BRCA1 mutations cause breast cancer
12-09-2007 · EurekAlert!
An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer. Findings show that one way BRCA1 mutations cause cancer is by knocking out a powerful tumor suppressor gene known as PTEN.
Similar news · Read more »
- Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
12-07-2006 · EurekAlert!
Common blood pressure medications might help block the spread of pancreatic cancer, researchers have found. The scientists showed in laboratory studies that two types of pressure-lowering drugs -- ACE inhibitors and AT1R blockers -- may help reduce the development of tumor-feeding blood vessels, a process called angiogenesis. Such drugs, they say, may become part of a novel strategy to control the growth and spread of cancer.
Similar news · Read more »
- Scripps Research study reveals new function of protein kinase pathway in tumor suppression
01-25-2007 · EurekAlert!
Scientists at the Scripps Research Institute have discovered a surprising new function of a well-known signaling pathway that, when activated, can inhibit tumor development. This finding may lead to the development of drugs that can serve as an effective cancer therapy by artificially activating this pathway in cancer cells.
Similar news · Read more »
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
